AtriCure traded at $42.58 this Friday May 27th, increasing $1.25 or 3.02 percent since the previous trading session. Looking back, over the last four weeks, AtriCure gained 23.15 percent. Over the last 12 months, its price fell by 42.16 percent. Looking ahead, we forecast AtriCure to be priced at 41.54 by the end of this quarter and at 38.54 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
42.58
Daily Change
3.02%
Yearly
-42.16%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 266.21 5.24 2.01% -6.46%
Abbott 116.63 1.76 1.53% -0.02%
AtriCure 42.58 1.25 3.02% -42.16%
Baxter International 76.17 0.42 0.55% -7.25%
Becton, Dickinson and Co. 256.43 3.93 1.56% 6.01%
Boston Scientific 41.19 1.05 2.60% -3.21%
Cooper Companies 352.18 8.47 2.46% -10.49%
Artivion Inc 19.21 0.14 0.73% -34.23%
Cardiovascular Systems 16.32 0.19 1.18% -58.28%
Dexcom 288.87 8.24 2.94% -21.80%
Edwards Lifesciences 101.12 2.55 2.59% 5.44%
Globus Medical 66.82 0.67 1.01% -6.87%
Integra LifeSciences 62.02 0.66 1.07% -10.07%
Inogen 25.55 -0.31 -1.20% -59.17%
Intuitive Surgical 229.13 5.83 2.61% -72.79%
J&J 181.11 1.65 0.92% 7.01%
Masimo 141.96 2.62 1.88% -34.52%
Medtronic 99.07 -0.37 -0.37% -21.74%
Merit Medical Systems 62.36 1.57 2.58% 2.52%
NuVasive 56.00 0.24 0.43% -18.22%
Insulet 233.57 4.51 1.97% -14.14%
ResMed 208.33 6.27 3.10% 1.20%
Stryker 236.45 1.51 0.64% -7.37%
Teleflex 290.21 4.74 1.66% -27.84%
Tandem Diabetes Care 70.33 2.96 4.39% -17.89%
Zimmer Biomet Holdings Inc 120.06 -0.59 -0.49% -28.38%

Indexes Price Day Year
USND 12131 390.48 3.33% -11.77%
US2000 1888 49.66 2.70% -16.80%

AtriCure
AtriCure, Inc. is a provider of technologies for the treatment of atrial fibrillation (Afib) and related conditions. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue, systems designed for the exclusion of the left atrial appendage, and devices designed to block pain by temporarily ablating peripheral nerves. These devices are developed and marketed to medical centers globally. Its ablation and left atrial appendage management (LAAM) products are used by physicians during both open-heart and minimally invasive procedures. Its products for open and minimally invasive ablation includes Isolator Synergy Clamp and Multifunctional Pens and Linear Ablation Devices. Its Product for open ablation are cryoICE Cryoablation System. Its product for minimally invasive ablation are EPi-Sense Guided Coagulation System with VisiTrax Technology. Its products for appendage management includes AtriClip System and LARIAT System.